DHG Pharmaceutical JSC (HOSE:DHG)
Vietnam
· Delayed Price · Currency is VND 100,000
+300 (0.30%)
At close: Apr 29, 2026
DHG Pharmaceutical JSC Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 901,792 | 852,354 | 778,920 | 1,050,663 | 988,455 | 777,220 | Upgrade
|
| Depreciation & Amortization | 118,229 | 118,029 | 169,695 | 88,704 | 81,001 | 82,564 | Upgrade
|
| Other Amortization | 999.68 | 978.85 | - | - | - | 1,299 | Upgrade
|
| Loss (Gain) From Sale of Assets | -116,228 | -120,583 | -139,127 | -203,609 | -112,319 | -106,218 | Upgrade
|
| Other Operating Activities | 26,247 | 17,665 | -9,538 | -11,828 | -56,715 | -43,544 | Upgrade
|
| Change in Accounts Receivable | -78,916 | -54,941 | 105,103 | -268,589 | 34,206 | 22,427 | Upgrade
|
| Change in Inventory | -30,587 | 86,655 | 420,960 | -286,890 | -177,950 | -246,313 | Upgrade
|
| Change in Accounts Payable | 29,156 | 289,927 | -21,510 | -129,051 | 160,321 | -33,242 | Upgrade
|
| Change in Other Net Operating Assets | 16,718 | 22,882 | 13,080 | 772.15 | -15,714 | -1,749 | Upgrade
|
| Operating Cash Flow | 867,410 | 1,212,968 | 1,317,583 | 240,171 | 901,285 | 452,444 | Upgrade
|
| Operating Cash Flow Growth | -33.46% | -7.94% | 448.60% | -73.35% | 99.20% | -45.24% | Upgrade
|
| Capital Expenditures | -46,294 | -31,136 | -88,705 | -486,343 | -233,992 | -24,562 | Upgrade
|
| Sale of Property, Plant & Equipment | 1,240 | 1,240 | 967.73 | 1,654 | 3,334 | 4,632 | Upgrade
|
| Investment in Securities | - | - | - | - | 3,206 | 84.72 | Upgrade
|
| Other Investing Activities | 119,148 | 120,628 | 156,786 | 179,869 | 118,723 | 101,430 | Upgrade
|
| Investing Cash Flow | 1,160,098 | 811,731 | -445,951 | -179,819 | -353,729 | 45,694 | Upgrade
|
| Short-Term Debt Issued | - | 1,321,447 | 1,708,085 | 1,524,390 | 737,941 | 794,683 | Upgrade
|
| Total Debt Issued | 792,840 | 1,321,447 | 1,708,085 | 1,524,390 | 737,941 | 794,683 | Upgrade
|
| Short-Term Debt Repaid | - | -1,971,361 | -1,630,335 | -1,066,949 | -830,609 | -799,564 | Upgrade
|
| Total Debt Repaid | -1,481,544 | -1,971,361 | -1,630,335 | -1,066,949 | -830,609 | -799,564 | Upgrade
|
| Net Debt Issued (Repaid) | -688,705 | -649,914 | 77,749 | 457,441 | -92,668 | -4,880 | Upgrade
|
| Common Dividends Paid | -784,476 | -1,307,461 | -980,596 | -457,611 | -457,611 | -522,984 | Upgrade
|
| Financing Cash Flow | -1,473,181 | -1,957,375 | -902,846 | -170.11 | -550,279 | -527,865 | Upgrade
|
| Foreign Exchange Rate Adjustments | -668.22 | -286.21 | -62.53 | -65.74 | -222.19 | 45.25 | Upgrade
|
| Net Cash Flow | 553,659 | 67,038 | -31,276 | 60,116 | -2,946 | -29,681 | Upgrade
|
| Free Cash Flow | 821,116 | 1,181,831 | 1,228,879 | -246,171 | 667,293 | 427,882 | Upgrade
|
| Free Cash Flow Growth | -32.70% | -3.83% | - | - | 55.95% | -41.97% | Upgrade
|
| Free Cash Flow Margin | 15.58% | 22.44% | 25.16% | -4.91% | 14.27% | 10.69% | Upgrade
|
| Free Cash Flow Per Share | 6280.23 | 9039.13 | 9398.97 | -1882.82 | 5103.73 | 3272.62 | Upgrade
|
| Cash Interest Paid | 19,875 | 26,020 | 24,766 | 29,299 | 12,558 | 12,050 | Upgrade
|
| Cash Income Tax Paid | 122,695 | 124,797 | 101,297 | 104,854 | 100,999 | 99,613 | Upgrade
|
| Levered Free Cash Flow | 688,355 | 554,112 | 1,955,870 | -506,459 | 447,363 | 260,730 | Upgrade
|
| Unlevered Free Cash Flow | 700,503 | 570,134 | 1,971,377 | -488,003 | 455,212 | 268,280 | Upgrade
|
| Change in Working Capital | -63,629 | 344,523 | 517,633 | -683,758 | 862.86 | -258,877 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.